У нас вы можете посмотреть бесплатно DAPT (GSI-IX): Unveiling Therapeutic Insights in Neuroscience and Cancer Research | GlpBio или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
DAPT, also known as GSI-IX, is a potent and selective inhibitor of γ-secretase, an enzyme complex that plays a crucial role in the processing of amyloid precursor protein (APP) and Notch receptors. This small molecule compound has been extensively studied for its potential therapeutic applications, particularly in the fields of neuroscience and cancer research. In the context of neuroscience, DAPT has been widely used to investigate the molecular mechanisms underlying Alzheimer's disease (AD). γ-secretase is responsible for the cleavage of APP, leading to the production of amyloid-beta (Aβ) peptides, which are known to aggregate and form the characteristic plaques found in the brains of AD patients. By inhibiting γ-secretase activity, DAPT can suppress the generation of Aβ peptides, making it a valuable tool for studying the pathogenesis of AD and potential therapeutic interventions. Furthermore, DAPT has been utilized to explore the role of Notch signaling in various physiological and pathological processes. Notch receptors are transmembrane proteins involved in cell fate determination, development, and tissue homeostasis. In cancer research, DAPT has been investigated for its potential as an anti-cancer agent due to its ability to block Notch signaling, which is often dysregulated in various malignancies. The pharmacological properties of DAPT have made it a valuable tool for both in vitro and in vivo studies. Researchers use DAPT to investigate the effects of inhibiting γ-secretase and Notch signaling in cell culture models, animal models, and tissue samples. Additionally, DAPT has been employed in drug discovery efforts aimed at developing novel therapeutic agents targeting γ-secretase and Notch signaling pathways. In summary, DAPT (GSI-IX) is a well-characterized inhibitor of γ-secretase with important implications for research in neurodegenerative diseases, cancer, and other fields. Its ability to modulate key signaling pathways and processes makes it a valuable tool for understanding disease mechanisms and exploring potential therapeutic strategies. For details please check: https://www.glpbio.com/dapt-gsi-ix.html